ADVFN ADVFN

Hot Features

Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
105.26
-3.44
(-3.16%)
終了 6月11日 5:00AM

Gilead Sciences Inc (GIS) 銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

主要統計と詳細

通貨
105.26
( -3.16% )
買値
105.16
売値
105.42
出来高
7,048
105.44 日の範囲 110.00
0.00 52 週間の範囲 0.00
時価総額
前日終値
108.70
始値
108.94
最終取引時間
財務取引量
-
VWAP
-
平均取引量 (3 か月)
6,390,826 €
発行済株式数
1,241,569,874
配当利回り
3.19 (2.50%)
PER
17.57
1 株当たり利益 (EPS)
7.35
歳入
29.74B
純利益
9.22B

Gilead Sciences Inc について

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Descovy, Genvoya, Odefsey, Sunlenca, Symtuza, and YeztugoFor the treatment of HIV... Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Descovy, Genvoya, Odefsey, Sunlenca, Symtuza, and YeztugoFor the treatment of HIV-1 infection in patients. It also provides Epclusa, Livdelzi, and Vemlidy to treat chronic hepatitis C virus, primary biliary cholangitis, and chronic hepatitis B virus; Tecartus, a T-cell therapy for the treatment of adult patients; Trodelvy, an injection for intravenous use; and Yescarta, a suspension for intravenous infusion, is a CAR T-cell therapy for the treatment of adult patients. Further, it provides AmBisome, for the treatment of serious invasive fungal infections; and Veklury for the treatment of COVID-19. Additionally, the company engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company has collaboration agreements with Shenzhen Pregene Biopharma Co., Ltd.; Abingworth; Arcus Biosciences, Inc.; Merck Sharp & Dohme Corp.; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Everest Medicines; Merck & Co, Inc.; Tentarix Biotherapeutics Inc.; and Assembly Biosciences, Inc. It also has research collaboration, option, and license agreement with Merus N.V. for the discovery of novel dual tumor-associated antigens (TAA) targeting trispecific antibodies. The company has a collaboration with Terray Therapeutics, Inc. to discover and develop small molecule therapies; and LEO Pharma to develop, manufacture, and commercialize the small molecule oral STAT6 program. The company was incorporated in 1987 and is headquartered in Foster City, California. 詳細を表示

セクター
Healthcare
業界
Pharmaceuticals
ウェブサイト
本社
Foster City, United States
設立
1987
Gilead Sciences Inc is listed in the Healthcare sector of the Tradegate (DE) with ticker GIS. The last closing price for Gilead Sciences was 108.70 €. Over the last year, Gilead Sciences shares have traded in a share price range of 0.00 € to 0.00 €.

Gilead Sciences currently has 1,241,569,874 shares in issue. The market capitalisation of Gilead Sciences is 130.69 € billion. Gilead Sciences has a price to earnings ratio (PE ratio) of 17.57.

GIS 最新ニュース

表示するニュースはありません。
期間 †前日比前日比 %始値高値安値平均出来高VWAP
10000000DE
40000000DE
120000000DE
260000000DE
520000000DE
1560000000DE
2600000000DE

GIS - Frequently Asked Questions (FAQ)

What is the current Gilead Sciences Inc share price?
The current share price of Gilead Sciences Inc is 105.26 €
How many Gilead Sciences Inc shares are in issue?
Gilead Sciences Inc has 1,241,569,874 shares in issue
What is the market cap of Gilead Sciences Inc?
The market capitalisation of Gilead Sciences Inc is EUR 130.69B
What is the 1 year trading range for Gilead Sciences Inc share price?
Gilead Sciences Inc has traded in the range of 0.00 € to 0.00 € during the past year
What is the PE ratio of Gilead Sciences Inc?
The price to earnings ratio of Gilead Sciences Inc is 17.57
What is the cash to sales ratio of Gilead Sciences Inc?
The cash to sales ratio of Gilead Sciences Inc is 5.39
What is the registered address of Gilead Sciences Inc?
The registered address for Gilead Sciences Inc is 333 Lakeside Drive, Foster City, California, 94404
What is the Gilead Sciences Inc website address?
The website address for Gilead Sciences Inc is www.gilead.com
Which industry sector does Gilead Sciences Inc operate in?
Gilead Sciences Inc operates in the Pharmaceuticals sector

GIS 取引

さらに

取引は遅延しています

リアルタイムの取引を取得するには、アカウントをアップグレードしてください

リアルタイムにアップグレード

最近閲覧した銘柄

Delayed Upgrade Clock